60
Participants
Start Date
November 30, 2010
Primary Completion Date
November 30, 2011
Study Completion Date
January 31, 2012
Aramchol
100mg/d tablets packaged in bottles given orally once a day in the morning within 10 minutes after breakfast for a total period time of 3 months
Aramchol
300 mg/d tablets packaged in bottles given orally once a day in the morning within 10 minutes after breakfast for a total period time of 3 months
Placebo
tablets packaged in bottles given orally once a day in the morning within approximately 10 minutes after breakfast
Safed Ziv Hospital, Safed
Rambam, Haifa
The Lady Davis Carmel Medical Center, Haifa
Hillel Yaffe Medical Center, Hadera
Meir Medical Center, Kfar Saba
Belinson,Rabin Medical Center, Petah Tikva
The Tel Aviv Sourasky Medical Center, Tel Aviv
Kaplan M.C, Rehovot
Soroka Medical Center, Beersheba
Hadassah Ein Kerem M.C, Jerusalem
Holy Family HOSPITAL, Nazareth
Lead Sponsor
Collaborators (1)
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Beilinson Hospital, Petach Tikva,Israel
UNKNOWN
Meir Medical Center
OTHER
Kaplan Hospital ,Rehovot,Israel
UNKNOWN
Soroka Hospital,Beer Sheva,Israel
UNKNOWN
Hadassah Medical Organization
OTHER
Hillel Yaffe Medical Center
OTHER_GOV
Rambam Hospital, Haifa, Israel
UNKNOWN
The Lady Davis Carmel Medical Center
UNKNOWN
Holy Family Hospital, Nazareth, Israel
OTHER
Ziv Hospital
OTHER_GOV
Galmed Medical Reserch
INDUSTRY